Keating Ashley M. 4
4 · Medpace Holdings, Inc. · Filed Mar 18, 2024
Insider Transaction Report
Form 4
Keating Ashley M.
Director
Transactions
- Sale
Common Stock
2024-03-14$409.87/sh−250$102,468→ 250 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-03-14−500→ 3,358 totalExercise: $84.36Exp: 2027-05-15→ Common Stock (500 underlying) - Exercise/Conversion
Common Stock
2024-03-14$84.36/sh+500$42,180→ 500 total
Footnotes (1)
- [F1]The option vested in full on May 13, 2021.